Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Outlines timing guidelines for rebalancing retirement accounts using index funds, including signals, thresholds, and practical cadence.
16,554 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Suncor Energy has climbed sharply this year, but is the rally justified for new buyers? This guide breaks down the dr...
The 2026 housing market predictions headline a continued stretch of seller pain and tighter credit. This guide breaks...
July has brought headlines that test investors' nerves. This piece breaks down what drove stock moves today, what Luc...
Ron Paul challenges President Trump’s move to hold government stakes in private companies, arguing it threatens liber...
ExxonMobil is not just drilling and refining anymore. This article explores how the company might evolve toward a bro...
Investors are turning their attention from faster GPUs to a broader shift in AI hardware. This next stage revolution ...
Meta AI projects a cycle bottom this year with a strong late-2026 rally for Bitcoin, hinging on regulatory clarity, r...
Single residents aim to live in Manhattan without roommates, but success hinges on an investment plan that covers hig...
As spacemobile nears commercial launch, investors wonder if this space-based cellular plan can disrupt the market. Th...
Meme coins surged with viral fame, but a political push to bar elected officials from launching them could reshape th...
AD Mortgage has sent a policy letter to the FHFA raising concerns about proposed condo financing criteria changes for...